Drug product development
AAIPharma has supported over 500 Investigational New Drug (IND) filings and over 50 New Drug Applications (NDA), Abbreviated New Drug Applications (ANDA) and New Animal Drug Applications ( NADA) over the past 30 years. AAIPharma specializes in all phases of pharmaceutical development – from critical preformulation studies to commercial product life-cycle management. Our comprehensive services are fully integrated to help our clients get the most out of their portfolio.
Our comprehensive pharmaceutical product development services include:
You might also like
Inform Genomics and Translational Drug Development (TD2) Announce .. — MarketWatch
.. LLC (TD2) based in Scottsdale, Arizona, today announced a strategic collaboration leveraging Inform Genomics' proprietary technology platform and analytic capabilities to biopharmaceutical companies through TD2's oncology drug development services.